Neu auf wallstreet:online?
Jetzt registrieren | Login
x
Benutzername:

Passwort:

Angemeldet bleiben
Passwort vergessen?

DGAP-News Burcon NutraScience Corp.: BURCON UPDATES ON PEAZAZZ(TM) DISCUSSIONS

Nachrichtenquelle: EQS Group AG
 |  24.04.2012, 11:25  |  412 Aufrufe  |   | 


DGAP-News: Burcon NutraScience Corp. / Key word(s): Miscellaneous
Burcon NutraScience Corp.: BURCON UPDATES ON PEAZAZZ(TM) DISCUSSIONS


24.04.2012 / 11:25




BURCON UPDATES ON PEAZAZZ(TM) DISCUSSIONS

Vancouver, British Columbia, April 23, 2012- Burcon NutraScience
Corporation (TSX - BU; NASDAQ - BUR) (´Burcon´) is pleased to provide an
update on the partnering discussions for our Peazazz(TM) pea protein. As
previously reported, Burcon has been in discussions with a potential
partner to commercialize Burcon´s Peazazz(TM) pea protein technology.
Discussions and due diligence with this party are ongoing, however, the
period of exclusivity has now lapsed.  Burcon continues to receive interest
for its invisible pea protein and will consider various routes-to-market.

Burcon´s Peazazz(TM) is a uniquely soluble and clean-tasting pea protein
isolate.  It is 100% soluble, transparent and heat stable in low pH
solutions.

´We are pleased with the level of interest we have received for our
Peazazz(TM) pea protein isolate, ´ said Johann F. Tergesen, president and
chief operating officer, adding, ´We will explore a variety of partnering
opportunities for commercialization of this exciting product.´

About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of
functional, renewable plant proteins. Since 1999, Burcon has developed a
portfolio of composition, application, and process patents originating from
our core protein extraction and purification technology.  We have developed
CLARISOY(TM) soy protein, the only vegetable-based protein that offers
clarity and complete protein nutrition for low pH beverage systems;
Peazazz(TM) a uniquely soluble and clean-tasting pea protein isolate and
Puratein(R), Supertein(TM) and Nutratein(TM) canola protein isolates with
unique functional and nutritional attributes.  Our team of highly
specialized scientists and engineers work from our private research
facility to develop and optimize environmentally sound technologies.
To-date, our patent portfolio consists of 186 issued patents in various
countries, including 33 issued U.S. patents, and in excess of 350
additional pending patent applications, 70 of which are U.S. patent
applications.

CLARISOY(TM) is under license to the Archer Daniels Midland Company.
CLARISOY(TM) is a trademark of Archer Daniels Midland Company.  

###

ON BEHALF OF THE BOARD OF DIRECTORS
´Johann F. Tergesen´
Johann F. Tergesen
President and Chief Operating Officer

The TSX has not reviewed and does not accept responsibility for the
adequacy of the content of the information contained herein. This press
release contains forward-looking statements that involve risks and
uncertainties. These forward-looking statements relate to, among other
things, plans and timing for the introduction or enhancement of our
products, statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in this
press release that are not historical fact. Our expectations regarding the
prospect for future success depend upon our ability to develop and sell
products, which we do not produce today and cannot be sold without further
research and development. When used in this press release, the words
´goal´, ´intend´, ´believes´ and ´potential´ and similar expressions,
generally identify forward-looking statements. These statements reflect our
current expectations. They are subject to a number of risks and
uncertainties. In light of the many risks and uncertainties surrounding the
development of a source of protein from canola meal, you should understand
that we cannot assure you that the forward looking statements contained in
this press release will be realized.

For more information, please contact:
Michael Kirwan, Director, Corporate Development
Burcon NutraScience Corporation
(604) 733-0896 / (888) 408-7960 toll-free
mkirwan@burcon.ca www.burcon.ca

End of Corporate News




24.04.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP´s Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de




166310 24.04.2012  

Schreibe Deinen Kommentar

 

Disclaimer

Nachrichtenquelle

Weitere Nachrichten des Autors

TitelLeser
288
276
228
218
208
204
200
196
194
192
TitelLeser
651
361
359
351
340
328
324
307
306
294
TitelLeser
3822
1025
932
790
710
694
651
597
591
577
TitelLeser
160603
10849
7297
6981
5827
5668
4350
4253
4239
3904